3-[N-(4-Chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-2-ethylpropanoic acid | 136668-66-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 3-[N-(4-Chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-2-ethylpropanoic acid
• 英文别名: 2-[[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)indol-2-yl]methyl]butanoic acid
• CAS: 136668-66-1
• 化学式: C₃₄H₃₅ClN₂O₃S
• 分子量: 587.182
• InChiKey: BTOHLGHSODUGQE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.2
• 重原子数：
  41
• 可旋转键数：
  11
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  89.6
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• (Quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes
  申请人：MERCK FROSST CANADA INC.

  公开号：EP0419049A1

  公开（公告）日：1991-03-27

  Compounds having the formula I: are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labor, spontaneous abortion, dysmenorrhea, and migraine.

  具有式 I 的化合物 是白三烯生物合成的抑制剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还可用于治疗腹泻、高血压、心绞痛、血小板聚集、脑痉挛、早产、自然流产、痛经和偏头痛。
• Naphthoic acid derivative
  申请人：FUJIREBIO INC.

  公开号：EP0492178A2

  公开（公告）日：1992-07-01

  A naphthoic acid derivative represented by the following general formula or a salt thereof: wherein Ri, R2 and R3 are each independently a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group, a lower alkoxy group, a lower alkanoyloxy group, a hydroxy-lower alkyl group, a lower alkoxy-lower alkyl group, a lower alkanoyloxy-lower alkyl group or an aralkyloxy group; R4 is a hydrogen atom or a lower alkyl group; R5 is a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaromatic group; X is a group a cycloalkylene group, a bivalent nitrogen-containing heterocyclic group, or a group -R8- NH- or -NH-R8, where R6 and R7 are each a hydrogen atom or a lower alkyl group and R8 is a cycloalkylene group, or R6 and R7, together with R4, may form an alkylene group of 1-3 carbon atoms; Y is -S(O)p-, -(CH2)n- or -0-; Z is a substituted or unsubstituted alkylene group or a single bond; ℓ is an integer of 0-4; m is an integer of 0-8; n is 0 or 1; p is an integer of 0-2; and g is 0 or 1. The compound is useful as an antiallergic agent.

  由以下通式代表的萘酸衍生物或其盐： 其中 Ri、R2 和 R3 各自独立地为氢原子、卤素原子、羟基、低级烷基、低级烷氧基、低级烷酰氧基、羟基-低级烷基、低级烷氧基-低级烷基、低级烷酰氧基-低级烷基或芳氧基； R4 是氢原子或低级烷基； R5 是取代或未取代的芳基或取代或未取代的杂芳基； X 是一个基团 环亚烷基、二价含氮杂环基团或基团 -R8-NH-或-NH-R8，其中 R6 和 R7 各为氢原子或低级烷基，R8 为环亚烷基，或 R6 和 R7 与 R4 可组成 1-3 个碳原子的亚烷基； Y 是-S(O)p-、-(CH2)n- 或-0-； Z 是取代或未取代的亚烷基或单键； ℓ 是 0-4 的整数； m 是 0-8 的整数 n 是 0 或 1； p 是 0-2 的整数；以及 g 为 0 或 1。 该化合物可用作抗过敏剂。
• Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
  申请人：Helgadottir Anna

  公开号：US20050113408A1

  公开（公告）日：2005-05-26

  Linkage of myocardial infarction (MI) and a locus on chromosome 13q12 is disclosed. In particular, the FLAP gene within this locus is shown by genetic association analysis to be a susceptibility gene for MI and ACS, as well as stroke and PAOD. Pathway targeting for treatment and diagnostic applications in identifying those who are at risk of developing MI, ACS, stroke or PAOD, in particular are described.

  本研究揭示了心肌梗塞（MI）与染色体 13q12 上一个位点的联系。特别是，遗传关联分析表明，该基因座上的 FLAP 基因是心肌梗死和急性心肌梗死以及中风和 PAOD 的易感基因。该研究还描述了用于治疗和诊断的路径靶向技术，特别是用于识别有患心肌梗死、心肌梗死综合症、中风或急性心肌梗死综合症风险的人群。
• Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
  申请人：Helgadottir Anna

  公开号：US20060019269A1

  公开（公告）日：2006-01-26

  Linkage of myocardial infarction (MI) and a locus on chromosome 13q12 is disclosed. In particular, the FLAP gene within this locus is shown by genetic association analysis to be a susceptibility gene for MI and ACS, as well as stroke and PAOD. Pathway targeting for treatment and diagnostic applications in identifying those who are at risk of developing MI, ACS, stroke or PAOD, in particular are described. The invention also provides for compositions comprising a leukotriene synthesis inhibitor and a stating and methods of using these compositions to reduce C-reactive protein in a human subject at risk of MI, ACS, stroke and/or PAOD.

  本研究揭示了心肌梗塞（MI）与染色体 13q12 上一个位点的联系。特别是，遗传关联分析表明，该基因座上的 FLAP 基因是心肌梗死和急性心肌梗死以及中风和 PAOD 的易感基因。本发明描述了用于治疗和诊断的靶向途径，特别是用于识别有患心肌梗死、心肌梗死综合症、中风或 PAOD 风险的人群。本发明还提供了包含白三烯合成抑制剂和说明的组合物，以及使用这些组合物降低有MI、ACS、中风和/或PAOD风险的人体内C反应蛋白的方法。
• SUSCEPTIBILITY GENE FOR MYOCARDIAL INFARCTION; METHODS OF TREATMENT
  申请人：Decode Genetics EHF.

  公开号：EP1579010A2

  公开（公告）日：2005-09-28